CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −7,619 | $181.88 | $1.4M | 73,071 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −4,286 | $182.60 | $783K | 68,785 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −4,032 | $183.92 | $742K | 64,753 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −3,243 | $184.91 | $600K | 61,510 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −3,636 | $185.93 | $676K | 57,874 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −1,572 | $187.15 | $294K | 56,302 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −1,400 | $187.97 | $263K | 54,902 |
| 2025-11-03 | Smith Michael Alexander Chief Legal Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −27,130 | 0 | ||
| 2025-09-12 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Option exercise 10b5-1 | +56,520 | $23.75 | $1.3M | 112,981 |
| 2025-09-12 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −32,091 | $144.60 | $4.6M | 80,890 |
| 2025-09-12 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −30,967 | $145.67 | $4.5M | 49,923 |
| 2025-09-12 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −7,304 | $146.57 | $1.1M | 42,619 |
| 2025-09-12 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −6,158 | $147.46 | $908K | 36,461 |
| 2025-09-12 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −56,520 | 0 | ||
| 2025-09-12 | SHAROKY MELVIN MD Director | Sale | −10,000 | $145.39 | $1.5M | 262,675 |
| 2025-09-11 | SHAROKY MELVIN MD Director | Gift | −2,000 | 272,516 | ||
| 2025-09-11 | SHAROKY MELVIN MD Director | Gift | −159 | 741 | ||
| 2025-09-11 | SHAROKY MELVIN MD Director | Gift | +159 | 272,675 | ||
| 2025-09-04 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Gift | −23,303 | 56,461 | ||
| 2025-09-02 | Smith Michael Alexander Chief Legal Officer | Option exercise 10b5-1 | +12,780 | $30.46 | $389K | 79,174 |
Page 16 of 23 · 448 trades